Illumina Body Map 2 (GSE30611)
Name | miRBASE accession |
---|---|
hsa-miR-137
|
MIMAT0000429 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 7.6 | GO:0051695 | actin filament uncapping(GO:0051695) |
0.3 | 5.2 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.3 | 4.9 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.2 | 4.2 | GO:0014894 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.2 | 4.1 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.8 | 4.0 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.1 | 3.8 | GO:0007194 | negative regulation of adenylate cyclase activity(GO:0007194) gamma-aminobutyric acid signaling pathway(GO:0007214) |
0.2 | 3.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 3.4 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 3.4 | GO:0060292 | long term synaptic depression(GO:0060292) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 13.4 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.2 | 6.8 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 6.1 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 6.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.1 | 5.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 4.5 | GO:0042583 | chromaffin granule(GO:0042583) |
0.2 | 4.4 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.2 | 4.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.0 | 4.3 | GO:0005778 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.4 | 4.0 | GO:0016012 | sarcoglycan complex(GO:0016012) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 10.3 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
1.2 | 7.3 | GO:0030375 | thyroid hormone receptor activator activity(GO:0010861) thyroid hormone receptor coactivator activity(GO:0030375) |
0.1 | 6.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 6.2 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 6.0 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.3 | 5.3 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.9 | 4.7 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 4.6 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.2 | 4.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.0 | 4.3 | GO:0005179 | hormone activity(GO:0005179) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.4 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 4.6 | PID FOXO PATHWAY | FoxO family signaling |
0.1 | 4.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 3.8 | PID MYC PATHWAY | C-MYC pathway |
0.1 | 3.2 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 3.2 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 3.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 2.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.1 | 2.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 2.1 | PID P53 REGULATION PATHWAY | p53 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 16.2 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 11.6 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 6.1 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 5.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.0 | 5.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 4.9 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.2 | 4.5 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.1 | 3.6 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 3.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 2.7 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |